Blood Pressure Recall: FDA Recalls 580,000 Bottles Made by Teva Pharmaceuticals.

You might want to take another look at your medicine cabinet.

More than 580,000 bottles of blood pressure medication with possible carcinogens have been recalled. According to the U.S. Food and Drug Administration (FDA).

New Jersey-based Teva Pharmaceuticals has recalled Prazosin Hydrochloride capsules because they “exceed the acceptable tolerance limit” for N-nitroso prazosin impurity C, a known carcinogen.

No side effects have been reported to date.

Read more: The FDA is recalling more than 140,000 bottles of this common statin. Is your drug one of them?

Here’s what you need to know about which capsules are being recalled and what to do if you have a recalled medication.

Which Prazosin Hydrochloride capsules are being recalled?

580,844 bottles of prazosin hydrochloride capsules were distributed nationwide and were released in 1 milligram, 2 milligram, and 5 milligram doses. According to the FDA.

A total of 55 lots of medication were recalled, including their lot codes. This is listed in the FDA notice.

According to the FDAThe pills were classified as drugs after they were first recalled on October 7. Level 2 recall October 24th.

A Class II recall means: “The product may cause adverse health effects that may be temporary or medically reversible.”

What should people who have recalled Prazosin Hydroclide capsules do?

Teva told NBC Chicago. The company sent letters about the recall to affected customers with instructions to return the recalled medication.

In the meantime, people taking the affected medications are encouraged to contact their pharmacy for further instructions on what to do with any remaining recalled medications.

“Consumers with questions or concerns should also contact their health care provider who prescribed the medication,” Teva said.